endogenous glp-1

endogenous glp-1 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to production and L-cell differentiation | Diabetology & Metabolic Syndrome Proposed mechanism of brain access

Name: endogenous glp-1 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to production and L-cell differentiation | Diabetology & Metabolic Syndrome Proposed mechanism of brain access
Brand: actil.am
SKU: 27077093170
Price: 21.90 USD
Availability: InStock
Rating: 4.7434 (5 reviews)

SKU: 27077093170

4.7

USD21.90 USD53.90

Pay in 4 interest-free payments of $5.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

Description

Looking ahead, the combination of ePA with other digital health trends could reshape GLP-1 management: Telehealth and Remote Initiation: If a patient sees a telehealth obesity specialist via video, that provider could use ePA to prescribe GLP-1 and get real-time approval without requiring an in-person follow-up for signature